- Report
- April 2025
- 170 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- February 2025
- 180 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- January 2026
- 150 Pages
Japan
From €4377EUR$4,850USD£3,792GBP
- Report
- September 2025
- 150 Pages
Canada
From €4377EUR$4,850USD£3,792GBP
- Report
- May 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- May 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2025
- 150 Pages
Global
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 170 Pages
Canada
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 205 Pages
China
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 242 Pages
India
From €4377EUR$4,850USD£3,792GBP
- Report
- March 2026
- 315 Pages
Germany
From €4377EUR$4,850USD£3,792GBP
- Report
- December 2025
- 150 Pages
Germany
From €4377EUR$4,850USD£3,792GBP
- Report
- November 2025
- 150 Pages
Japan
From €4377EUR$4,850USD£3,792GBP
- Report
- July 2025
- 150 Pages
Saudi Arabia
From €4377EUR$4,850USD£3,792GBP
- Report
- July 2025
- 150 Pages
Turkey
From €4377EUR$4,850USD£3,792GBP
- Report
- July 2025
- 150 Pages
South Africa
From €4377EUR$4,850USD£3,792GBP
- Report
- July 2025
- 150 Pages
Malaysia
From €4377EUR$4,850USD£3,792GBP
- Report
- July 2025
- 150 Pages
Italy
From €4377EUR$4,850USD£3,792GBP
- Report
- July 2025
- 150 Pages
Indonesia
From €4377EUR$4,850USD£3,792GBP

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more